Published in
Public Library of Science, PLoS ONE, 1(9), p. e85430, 2014
DOI: 10.1371/journal.pone.0085430
Links
- ORCID
- Public Library of Science
- [www.ncbi.nlm.nih.gov] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [serval.unil.ch] | PDF
Tools
Effectiveness of Anti-Psychotics and Related Drugs in the Huntington French-Speaking Group Cohort
Journal article published in 2014 by
Gaëlle Désaméricq,
Guillaume Dolbeau,
Christophe Verny,
Perrine Charles,
Alexandra Durr,
Katia Youssov,
Clemence Simonin,
Jean-Philippe Azulay,
Christine Tranchant 
,
Cyril Goizet,
Philippe Damier,
Emmanuel Broussolle,
Jean-François Demonet,
Jean-François Démonet,
Graca Morgado
and other authors.
,
Cyril Goizet,
Philippe Damier,
Emmanuel Broussolle,
Jean-François Demonet,
Jean-François Démonet,
Graca Morgado
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 
Abstract
Purpose: Huntington's disease is a rare condition. Patients are commonly treated with antipsychotics and tetrabenazine. The evidence of their effect on disease progression is limited and no comparative study between these drugs has been conducted. We therefore compared the effectiveness of antipsychotics on disease progression.